Quarterly report [Sections 13 or 15(d)]

Stockholders' Equity (Tables)

v3.26.1
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2026
Stockholders' Equity  
Schedule of Stock-Based Compensation Expense

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended June 30, 

​

​

Six Months Ended June 30, 

($ in thousands)

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

​

2026

  ​ ​ ​

2025

Fortress:

​

​

​

​

​

​

​

​

​

​

​

​

​

Employee and non-employee awards

​

$

1,225

​

$

2,916

​

​

$

1,768

​

$

5,523

Executive awards

​

 

134

​

 

180

​

​

 

267

​

 

360

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Partner Companies:

​

 

​

​

​

​

​

​

​

​

​

​

​

Avenue

​

 

61

​

 

175

​

​

 

122

​

 

360

Checkpoint

​

 

—

​

 

12,141

​

​

 

—

​

 

14,097

Mustang

​

 

21

​

 

45

​

​

 

43

​

 

83

Journey

​

​

1,437

​

​

1,336

​

​

​

2,426

​

​

2,659

Other

​

 

—

​

 

—

​

​

 

8

​

 

—

Total stock-based compensation expense

​

$

2,878

​

$

16,793

​

​

$

4,634

​

$

23,082

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended June 30, 

​

​

Six Months Ended June 30, 

($ in thousands)

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

​

2026

  ​ ​ ​

2025

Research and development

​

$

35

​

$

4,751

​

​

$

60

​

$

6,093

Selling, general and administrative

​

 

2,843

​

 

12,042

​

​

 

4,574

​

 

16,989

Total stock-based compensation expense

​

$

2,878

​

$

16,793

​

​

$

4,634

​

$

23,082

Schedule of Restricted Stock Awards and Restricted Stock Units

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

Weighted

​

​

​

​

average grant

​

​

Number of shares

​

price

Unvested balance at December 31, 2025

​

3,841,748

​

$

3.62

Restricted stock granted

​

1,087,458

​

​

3.22

Restricted stock vested

​

(37,037)

​

​

17.33

Restricted stock units granted

​

425,000

​

​

3.16

Restricted stock units forfeited

​

(150,000)

​

​

1.72

Restricted stock units vested

​

(219,877)

​

​

18.27

Unvested balance at June 30, 2026

​

4,947,292

​

$

2.80

Schedule of Warrant activities

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Total weighted

​

Weighted average

​

​

​

​

​

​

​

average

​

remaining

​

​

Number of

​

Weighted average

​

 intrinsic

​

contractual life

​

  ​ ​ ​

shares

  ​ ​ ​

exercise price

  ​ ​ ​

value

  ​ ​ ​

(years)

Outstanding as of December 31, 2025

 

13,431,502

​

$

2.21

​

$

—

 

3.55

Exercised

​

(694,296)

​

​

1.76

​

​

—

​

—

Outstanding as of June 30, 2026

 

12,737,206

​

$

2.24

​

$

11,737,518

 

3.05

Exercisable as of June 30, 2026

 

12,737,206

​

$

2.24

​

$

11,737,518

 

3.05